Presentation is loading. Please wait.

Presentation is loading. Please wait.

Bjorn van Anrooij, MD, Joanne N. G. Oude Elberink, MD, PhD, Lambert F

Published byReidar Finstad Modified over 6 years ago

Similar presentations

Presentation on theme: "Bjorn van Anrooij, MD, Joanne N. G. Oude Elberink, MD, PhD, Lambert F"— Presentation transcript:

1 Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial 
Bjorn van Anrooij, MD, Joanne N.G. Oude Elberink, MD, PhD, Lambert F.R. Span, MD, PhD, Jan G.R. de Monchy, MD, PhD, Stefano Rosati, MD, André B. Mulder, MD, PhD, Johanna C. Kluin-Nelemans, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 142, Issue 3, Pages e7 (September 2018) DOI: /j.jaci Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Percentage change in symptom severity as measured by using the MSAF score halfway and after 24 weeks. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Serum tryptase level reduction during midostaurin treatment.
Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig E1 Patient accrual and trial profile. SSM, Smoldering systemic mastocytosis. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E2 Symptom severity as measured by using the median MSAF score before and after 24 weeks of treatment with midostaurin: the higher the score, the more severe the symptoms. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E3 Response in mast cell (MC) infiltration markers after 24 weeks of midostaurin. Each bar represents a single patient. Methylhistamine and methylimidazole acetic acid levels were measured in morning urine samples voided on waking. SCORMA, Scoring Mastocytosis Index. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E4 Median scores per domain of the disease-specific Mastocytosis Quality-of-Life Questionnaire (MQLQ)– and the general Short Form Health Survey 36 (SF36)–related quality of life. A higher score indicates less burden. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Fig E5 Effect of midostaurin dosage tapering on tryptase level and symptom severity during 12 months of follow-up. Journal of Allergy and Clinical Immunology  , e7DOI: ( /j.jaci ) Copyright © 2018 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Bjorn van Anrooij, MD, Joanne N. G. Oude Elberink, MD, PhD, Lambert F"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,

Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis  Eveline van der Veer, PhD, Suzanne Arends, PhD, Sjoukje van der.

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis  Eveline van der Veer, PhD, Suzanne Arends, PhD, Sjoukje van der.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Prevalence of indolent systemic mastocytosis in a Dutch region

Prevalence of indolent systemic mastocytosis in a Dutch region
Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,

Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery  Albertien A.C. Aukema,
Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A

Jay A. Lieberman, MD, Faith R. Huang, MD, Hugh A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement  Shradha Agarwal, MD, Charlotte Cunningham-Rundles,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Advancing asthma care: The glass is only half full!

Advancing asthma care: The glass is only half full!
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J

Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents  Bertine M.J. Flokstra-de Blok, MSc, Audrey.

Development and validation of the self-administered Food Allergy Quality of Life Questionnaire for adolescents  Bertine M.J. Flokstra-de Blok, MSc, Audrey.

Similar presentations

Ads by Google